A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier BV in Kidney International
- Vol. 58 (1), 317-324
- https://doi.org/10.1046/j.1523-1755.2000.00168.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Levamisole for corticosteroid-dependent nephrotic syndrome in childhoodThe Lancet, 1991
- Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.JCI Insight, 1991
- Cyclosporine-induced remission of relapsing nephrotic syndrome in childrenThe Journal of Pediatrics, 1987
- LONG-TERM OUTCOME FOR CHILDREN WITH MINIMAL-CHANGE NEPHROTIC SYNDROMEThe Lancet, 1985
- Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid miceClinical Immunology and Immunopathology, 1984
- Effect of Cytotoxic Drugs in Frequently Relapsing Nephrotic Syndrome with and without Steroid DependenceNew England Journal of Medicine, 1982
- Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularityKidney International, 1981
- Long-Term Evaluation of Chlorambucil plus Prednisone in the Idiopathic Nephrotic Syndrome of ChildhoodNew England Journal of Medicine, 1980
- Chlorambucil and LeukemiaNew England Journal of Medicine, 1977
- CYCLOPHOSPHAMIDE TREATMENT IN STEROID-SENSITIVE NEPHROTIC SYNDROME OF CHILDHOODThe Lancet, 1975